Search

everythinglearnresearchcommunity

for

Search:↓

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Baricitinib is widely used for several conditions, especially COVID-19, but its safety and effectiveness are still being evaluated.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Cancer treatments can cause various eye problems, so eye doctors should know how to diagnose and treat these early.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

Reducing gefitinib dosage improved hair loss, but scarring remained.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Upadacitinib effectively treats pyoderma gangrenosum.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

Ebastine may help regrow hair in alopecia areata patients.

Baricitinib is a safe and effective treatment for alopecia areata, with better results in patients with lower initial severity, shorter disease duration, and longer treatment.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Both treatments are similarly effective, but paclitaxel-carboplatin is cheaper and has more severe side effects.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

M50054 may help treat hepatitis and hair loss from chemotherapy.